Synopsys (SNPS) FY2013 results: revenue $2.0 billion, up 11.7% on the year
Synopsys Inc. (SNPS) reported revenue of $2.0 billion for fiscal 2013, the year ended 31 October 2013, up 11.7% on the year before. Net income was $248 million, up 36.2%, and diluted earnings per share $1.58. The figures are the company's own, from the 10-K it filed with the SEC on 20 December 2013.
Revenue
$2.0 billion
+11.7% on the year
FY2008FY2013
Operating margin
12.6%
10.8% a year earlier
FY2008FY2013
Net income
$248 million
+36.2% on the year
FY2008FY2013
Diluted EPS
$1.58
+30.6% on the year
FY2008FY2013
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2013
FY2012
FY2011
On the year
Last 8 years
Revenue
1,962
1,756
1,536
+11.7%
Cost of revenue
454
393
340
+15.5%
Gross profit
1,509
1,363
1,195
+10.7%
Gross margin
76.9%
77.6%
77.8%
Research and development
669
582
492
+15.1%
Operating income
246
190
213
+29.7%
Operating margin
12.6%
10.8%
13.9%
Interest expense
1.7
2.0
0.1
-14.8%
Pre-tax income
276
201
219
+37.1%
Income tax
27.9
18.7
-2.3
+48.8%
Effective tax rate
10.1%
9.3%
-1.0%
Net income
248
182
221
+36.2%
Net margin
12.6%
10.4%
14.4%
Diluted EPS
$1.58
$1.21
$1.47
+30.6%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2013
FY2012
FY2011
On the year
Last 8 years
Operating cash flow
497
486
440
+2.2%
Capital expenditure
65.5
54.2
57.3
+20.8%
Free cash flow
431
432
383
-0.1%
Free cash flow margin
22.0%
24.6%
24.9%
Cash from investing
-66.1
-879
-88.8
Cash from financing
-98.0
243
-278
Depreciation and amortisation
187
157
129
+19.5%
Share-based compensation
67.5
71.4
56.4
-5.5%
Buybacks
145
40.0
402
+262.5%
Diluted shares, weighted
157m
150m
150m
+4.2%
Shares outstanding at period end
154m
151m
143m
+2.2%
Balance sheet
$ million
FY2013
FY2012
FY2011
On the year
Last 8 years
Shareholders' equity
2,788
2,502
2,101
+11.5%
Non-controlling interest
n/a
42.3
n/a
Debt
105
135
0.0
-22.2%
Other liabilities
1,466
1,469
1,266
-0.2%
Total liabilities and equity
4,359
4,148
3,367
+5.1%
Fixed assets
198
191
160
+3.3%
Goodwill
1,976
1,977
1,289
-0.1%
Intangible assets
335
466
196
-28.1%
Investments
n/a
n/a
149
Cash and equivalents
1,022
700
855
+46.0%
Receivables
256
293
203
-12.5%
Other assets
571
520
515
+9.9%
Total assets
4,359
4,148
3,367
+5.1%
10-K for the year ended 31 October 2013, filed 20 December 2013: the filing.